02.06.2014 Views

Pharma:

Pharma:

Pharma:

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Darshan Kulkarni,<br />

Pharm.D, MS, Esq.<br />

Principal Attorney<br />

<strong>Pharma</strong>:<br />

Developing a Social<br />

Media Policy


Disclaimer<br />

THIS INFORMATION DOES NOT CONSTITUTE LEGAL<br />

ADVICE. TO DETERMINE IF ADVICE IS APPROPRIATE<br />

FOR YOU, YOU MUST TALK TO A LAWYER AT THE<br />

FIRM AND CREATE AN ATTORNEY-CLIENT<br />

RELATIONSHIP.


Pharm.D<br />

JD<br />

MS in<br />

QA/RA


Entrepreneur<br />

Attorney<br />

Author<br />

<strong>Pharma</strong>cist<br />

Educator<br />

Regulatory


Compliance<br />

Legal<br />

Regulatory


Par<br />

<strong>Pharma</strong><br />

Unsolicited<br />

Off Label<br />

Guidance<br />

Clin. Trial Payments to<br />

Uni. Hospitals > FMV<br />

Updates<br />

Sunshine<br />

Act<br />

Guidance<br />

Alfred<br />

Coronia<br />

Case<br />

Fines<br />

Citizens<br />

Petition


What are 3 elements you want in your<br />

employee's company Twitter account?<br />

1. ______________________<br />

2. ______________________<br />

3. ______________________<br />

Your Social<br />

Media Policy


• What is this presentation NOT about?<br />

• Social Media Definition<br />

• Participating in Social Media- Pros & Cons<br />

• Review of FDA Promotions<br />

• General Tips in Social Media Policies<br />

• Current State of Social Media & <strong>Pharma</strong> Today<br />

• Good Promotion Practices<br />

• Crystal Ball<br />

• Take Away<br />

Outline


What is this<br />

presentation NOT<br />

about?<br />

Should you do social media?<br />

• 80% of Internet users have for such as a specific<br />

disease or treatment.


What is this<br />

presentation NOT<br />

about?<br />

How to do social media?<br />

I am not a marketing guy.


What is this<br />

presentation NOT<br />

about?<br />

How to evaluate ROI?<br />

Not my focus or specialty.


Definition<br />

What is social media?<br />

Is it a bird??<br />

Is it a plane?<br />

No... It’s _____________________________


Participating in<br />

Social Media<br />

Pros and Cons


Pros<br />

• That’s where most of your patients are.


Pros<br />

• It is instantaneous.


Pros<br />

It reaches a wide audience.


Cons<br />

• Once something is out there, there is no<br />

taking it back.


Cons<br />

• There is so much information out there.<br />

How do you control it?


Cons<br />

• If I don’t know about it, do I have plausible<br />

deniability?


Cons<br />

• Difficult to measure ROI


Cons<br />

• Inadequate Guidance


Social Media<br />

Policies<br />

General Discussion


Code of Conduct<br />

Sexual Harassment Policy<br />

Discrimination Policy<br />

Confidentiality<br />

Use of Company Logos/ Images


• Cross-linking v. Downloading<br />

policies<br />

Social Media Dos


• DMCA Concerns<br />

•Have take down policies in place<br />

Social Media Dos


Monitor company owned electronics<br />

Social Media Dos


Decide which sites you will “adopt”<br />

• Monitor those sites<br />

Social Media Dos


Record Keeping<br />

Updates<br />

Do you have right<br />

policies/ Procedures<br />

Do you have MSL/<br />

Med Aff Buy-in?<br />

Social Media Dos<br />

Are you going to have off-label<br />

discussions?


You are the brand manager for a drug that is FDAapproved<br />

for GERD. You found a great explanation<br />

for GERD on YouTube. Should you post a link using<br />

your corporate Twitter account to that GERD page?<br />

What Should You Do?


Social Media Don'ts<br />

1. Both union and non-union workplaces are<br />

subject to National Labor Relations Act (NLRA)<br />

and National Labor Relations Board (NLRB).<br />

2. NLRB has filed several complaints against<br />

companies for firing employees based on their<br />

Facebook postings - postings were protected<br />

activity.


Social Media Don'ts<br />

Using parent/subsidiary policy may<br />

result in global exposure.<br />

• Piercing the corporate veil.


A physician, your personal friend, is<br />

looking for information on GERD. Your<br />

company sells medication for reflux.<br />

You are the marketing manager, and<br />

are hence aware of the latest standard<br />

of care guidelines on GERD. You<br />

happen to know that they are posted<br />

on a reputable website:<br />

www.MDGERDlink.com. Can you link<br />

to the information for your friend using<br />

a personal account?<br />

What Should You Do?


Promotions<br />

Recap


Promotions v.<br />

Scientific Discussions


Types of<br />

DTC Ads<br />

• Help Seeking Ad<br />

• If done right, governed by FTC<br />

• Cannot use name of drug


Types of DTC Ads<br />

Reminder Ad<br />

• Can use name of drug<br />

• Cannot hint/name disease


Types of DTC Ads<br />

Product Claim Ad<br />

• Can name drug and disease<br />

• Must balance with risks of drug


Social Media and <strong>Pharma</strong><br />

The Current Status


Current State<br />

• Distinguish between controlled<br />

and uncontrolled sites


Current State<br />

• Off-label discussions:<br />

• - When is there a solicitation?


Current State<br />

• Astra Zeneca: Twitter Chats


Mistakes &<br />

Miscommunications<br />

• The “one click rule" is dead<br />

• 2009<br />

• 14 companies concerning Google banner ads:<br />

• Failed to include risk information<br />

• FDA stated it "never had what some are referring to as a<br />

one click rule”


• The "Invisibility Rule" does not exist<br />

o What happened?<br />

o What if the "patient/audience" caused<br />

the meta-data to appear?<br />

The Invisibility Rule


Open Questions<br />

• Brief summary with limited space<br />

• Correcting misinformation


Enforcement Actions<br />

Trending


Examples of<br />

Enforcement Actions<br />

• Facebook widget: Metadata<br />

• YouTube: Shire/ Adderall XR:<br />

Overstatement of efficacy<br />

• Omitting risk<br />

• Wikipedia: Who edits? Controls?


What Should You Do?<br />

You are the brand manager of a new<br />

GERD medication that was launched 4<br />

months ago. You notice that your<br />

brand’s competitor has edited your<br />

drug’s Wikipedia page to add side<br />

effects that have not been associated<br />

with your drug.<br />

1. Edit the Wikipedia page from your office computer to<br />

reflect actual SEs observed.<br />

2. Go home and edit the Wikipedia page to reflect the<br />

actual SEs observed.<br />

3. Have your 22-year-old son edit the page from his<br />

dorm room in southern California.<br />

4. None of the above


What Should You Do?<br />

This time, you notice that a patient edited<br />

your Wikipedia page to add a new<br />

indication that, while it is the standard of<br />

care, is not an FDA-approved indication.<br />

Option 1<br />

Option 2:<br />

Option 3<br />

Edit wikipedia page from your<br />

office<br />

Do nothing<br />

Something else (if so, what)


Enforcement Actions


Why is MLR Pushing Back?<br />

Company<br />

Level<br />

Fines<br />

Exclusions<br />

Sale of Company<br />

Individual<br />

Level<br />

Fines<br />

Exclusions<br />

Criminal Penalties<br />

Personal Shame<br />

Loss of Licenses


Good Promotion<br />

Practices


Good <strong>Pharma</strong> Social Media<br />

Promotion Practices<br />

• Have a social media policy in place


Good <strong>Pharma</strong> Social Media<br />

Promotion Practices<br />

• Who represents the company?


Good <strong>Pharma</strong> Social<br />

Media Promotion<br />

Practices<br />

• Do things need to be run by<br />

legal/compliance?


Good <strong>Pharma</strong> Social Media<br />

Promotion Practices<br />

• What happens with reported AEs?


Good <strong>Pharma</strong> Social Media<br />

Promotion Practices<br />

• Will you promote a product/disease/<br />

company/risk mitigation?


Monitor<br />

Use Third Parties to<br />

evaluate without bias<br />

Follow<br />

Up on<br />

Risks<br />

Create<br />

SOPs<br />

Identify<br />

Risks


Crystal Ball<br />

The Future of Social Media in <strong>Pharma</strong>


Your SM Policy<br />

What are 3 elements you want in your<br />

employee's company accounts?<br />

1.______________________<br />

2.______________________<br />

3.______________________


Do they<br />

represent<br />

Company?<br />

Which division of<br />

company do they<br />

represent?<br />

Link to terms of<br />

engagement<br />

Can you take<br />

AEs<br />

If no, where<br />

should they<br />

be reported?<br />

What is site’s<br />

purpose?<br />

Explain why<br />

you cant<br />

engage


Social Media Guidances<br />

FDA is expected to have the following guidances:


Responding to unsolicited requests<br />

Fulfilling regulatory requirements when using tools<br />

associated with space limitations<br />

Fulfilling post-marketing submission requirements<br />

Online communications for which manufacturers,<br />

packers, or distributors are accountable<br />

Use of links on the Internet


Future of Social<br />

Media<br />

• DDMAC is dead. Long live OPDP.


IMS v.<br />

Sorrell<br />

Citizens<br />

Petition<br />

Par<br />

<strong>Pharma</strong><br />

Alfred<br />

Coronia


... but we don’t have<br />

all the SM Guidances?<br />

FDA has continually said:<br />

• Don’t expect rules to change<br />

• Clarifications will be provided


Take Away<br />

• The rules have changed.<br />

• It’s a brave new world out there.<br />

• But: If they don’t give you a<br />

map, they blame you for not<br />

following directions


Questions?<br />

@FDALawyers<br />

Join us to chat at #rxcom<br />

@9pm on 1 st Monday of every month


Darshan Kulkarni<br />

Darshan@conformlaw.com<br />

Phone: 215-703-7842<br />

http://www.conformlaw.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!